NCT01734525View on ClinicalTrials.gov

Negative Beta Glucan in ICU Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Candidemia
Interventions
DRUG

Anidulafungin

Anidulafungin at a dose of 200 mg in the first day and 100 mg daily afterwards

Trial Locations (1)

21941913

Federal University of Rio de Janeiro, Rio de Janeiro

All Listed Sponsors
lead

Universidade Federal do Rio de Janeiro

OTHER

NCT01734525 - Negative Beta Glucan in ICU Patients | Biotech Hunter | Biotech Hunter